Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-06-14
2011-06-14
Bland, Layla (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S025000
Reexamination Certificate
active
07960522
ABSTRACT:
Compounds that are adjuvants and immunoeffectors are described and claimed. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Compositions and methods for using the compounds as adjuvants and immunoeffectors are also disclosed.
REFERENCES:
patent: 5593969 (1997-01-01), Kamireddy et al.
patent: 6113918 (2000-09-01), Johnson et al.
patent: 6303347 (2001-10-01), Johnson et al.
patent: 6355257 (2002-03-01), Johnson et al.
patent: 6525028 (2003-02-01), Johnson et al.
patent: 6699846 (2004-03-01), Elliott et al.
patent: 6764840 (2004-07-01), Johnson et al.
patent: 6800613 (2004-10-01), Persing et al.
patent: 6911434 (2005-06-01), Baldridge et al.
patent: 7030094 (2006-04-01), Mossman et al.
patent: 7063967 (2006-06-01), Johnson et al.
patent: 7129269 (2006-10-01), Reed et al.
patent: 2003/0092643 (2003-05-01), Johnson et al.
patent: 2003/0199460 (2003-10-01), Johnson et al.
patent: WO 98/50399 (1998-11-01), None
patent: WO 01/34617 (2001-05-01), None
patent: WO 0136433 (2001-05-01), None
patent: WO 2004/005308 (2004-01-01), None
patent: WO 2004/062599 (2004-07-01), None
Christ et al. Science, vol. 268, Apr. 7, 1995, pp. 80-83.
Watanabe et al. Carbohydrate Research 333 (2001) 203-231.
Persing, David H. et al.; “Taking toll: lipid A mimetics as adjuvants and immunomodulators”; 2002,Trends in Microbiology, vol. 10, No. 10, pp. S32-S37.
Stover, Axel G. et al.; “Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists”; 2004,The Journal of Biological Chemistry, vol. 279, No. 6, pp. 4440-4449.
Matsuura et al., Expression of endotoxic activities by synthetic monosaccharide Lipid A analogs with alkyl-branched acyl substituents; Infection and Immunity (1995) vol. 63 pp. 1446-1451.
Shiozaki et al., Synthesis of a 3-ether analogue of Lipid A; Carbohydrate Research 1991, vol. 222 pp. 69-82.
Mochizuki et al., Lipid A-type pyrancarboxylic acid derivatives, their synthesis and their biological activities (2000), Tetrahedron, vol. 56, pp. 7691-7703.
Lien et al., A novel synthetic acyclic Lipid A-like antagonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway; J. Biol. Chem. (2001), vol. 276 pp. 1873-1880.
Watanabe et al., Synthesis of Lipid A type carboxymethyl derivatives with ether chains instead of ester chains and their LPS-antagonistic activities (2003), Carbohydrate Research vol. 338 pp. 47-54.
Johnson et al.; “Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs)”;Bioorg. Med. Chem. Lett.; 9(15): 2273-2278 (1999).
Johnson David A.
Persing David
Bland Layla
Corixa Corporation
Kilpatrick Townsend & Stockton LLP
LandOfFree
Certain aminoalkyl glucosaminide phosphate compounds and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain aminoalkyl glucosaminide phosphate compounds and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain aminoalkyl glucosaminide phosphate compounds and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2647413